Abstract
Objectives
The objective of the present work was to assess the level of evidence in economic evaluations of percutaneous left atrial appendage closure devices, and to test the complementarity of three different tools for assessing the quality of economic evaluations.
Methods
We conducted a systematic review of articles in English or French listed in MEDLINE, Embase, Cochrane, the Cost-Effectiveness Analysis registry and the National Health Service Economic Evaluation Database. We included only economic evaluations concerning left atrial appendage closure devices. Data were extracted from articles by two authors working independently and using three analysis grids to measure the quality of economic evaluations [the British Medical Journal (BMJ) checklist, the hierarchy scale developed by Cooper et al. (J Health Serv Res Policy 10:245–50, 2005) and the Quality of Health Economic Studies (QHES) instrument].
Results
Seven economic evaluations met our inclusion criteria. All were published between 2013 and 2016. All were cost-utility analyses, and fully complied with the BMJ checklist. According to the hierarchy scale developed by Cooper et al., the quality of data used was heterogeneous. Finally, the mean score for the seven economic studies was 90/100 with the QHES instrument.
Conclusions
Despite the recent development of left atrial appendage closure devices, most economic evaluations conducted here were well-designed studies. Furthermore, different tools used to assess the quality of these studies were complementary, but none gave a global vision of the quality of economic studies.
Similar content being viewed by others
References
Lane DA, Lip GYH. Use of the CHA(2)DS(2)-VASc and HAS-BLED scores to aid decision making for thromboprophylaxis in nonvalvular atrial fibrillation. Circulation. 2012;126:860–5.
Mahajan R, Brooks AG, Sullivan T, Lim HS, Alasady M, Abed HS, et al. Importance of the underlying substrate in determining thrombus location in atrial fibrillation: implications for left atrial appendage closure. Heart Br Card Soc. 2012;98:1120–6.
Ostermayer SH, Reisman M, Kramer PH, Matthews RV, Gray WA, Block PC, et al. Percutaneous left atrial appendage transcatheter occlusion (PLAATO system) to prevent stroke in high-risk patients with non-rheumatic atrial fibrillation: results from the international multi-center feasibility trials. J Am Coll Cardiol. 2005;46:9–14.
Holmes DR, Kar S, Price MJ, Whisenant B, Sievert H, Doshi SK, et al. Prospective randomized evaluation of the Watchman Left Atrial Appendage Closure device in patients with atrial fibrillation versus long-term warfarin therapy: the PREVAIL trial. J Am Coll Cardiol. 2014;64:1–12.
Holmes DR, Reddy VY, Turi ZG, Doshi SK, Sievert H, Buchbinder M, et al. Percutaneous closure of the left atrial appendage versus warfarin therapy for prevention of stroke in patients with atrial fibrillation: a randomised non-inferiority trial. Lancet Lond Engl. 2009;374:534–42.
Drummond M, Griffin A, Tarricone R. Economic evaluation for devices and drugs–same or different? Value Health J Int Soc Pharmacoeconomics Outcomes Res. 2009;12:402–4.
Ciani O, Wilcher B, van Giessen A, Taylor RS. Linking the Regulatory and Reimbursement Processes for Medical Devices: The Need for Integrated Assessments. Health Econ. 2017;26(Suppl 1):13–29.
Boudard A, Martelli N, Prognon P, Pineau J. Clinical studies of innovative medical devices: what level of evidence for hospital-based health technology assessment? J Eval Clin Pract. 2013;19:697–702.
Sorenson C, Drummond M, Bhuiyan Khan B. Medical technology as a key driver of rising health expenditure: disentangling the relationship. Clin Outcomes Res CEOR. 2013;5:223–34.
Martelli N, Devaux C, van den Brink H, Pineau J, Prognon P, Borget I. A systematic review of the level of evidence in economic evaluations of medical devices: the example of vertebroplasty and kyphoplasty. PLoS One. 2015;10:e0144892.
Moher D, Liberati A, Tetzlaff J, Altman DG, PRISMA Group. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. Int J Surg Lond Engl. 2010;8:336–41.
Schardt C, Adams MB, Owens T, Keitz S, Fontelo P. Utilization of the PICO framework to improve searching PubMed for clinical questions. BMC Med Inform Decis Mak. 2007;7:16.
Teerawattananon Y, Russell S, Mugford M. A systematic review of economic evaluation literature in Thailand: are the data good enough to be used by policy-makers? PharmacoEconomics. 2007;25:467–79.
Drummond MF, Sculpher MJ, Claxton K, Stoddart GL, Torrance GW. Methods for the economic evaluation of health care programmes. Oxford: Oxford University Press; 2015.
Cooper N, Coyle D, Abrams K, Mugford M, Sutton A. Use of evidence in decision models: an appraisal of health technology assessments in the UK since 1997. J Health Serv Res Policy. 2005;10:245–50.
Ofman JJ, Sullivan SD, Neumann PJ, Chiou C-F, Henning JM, Wade SW, et al. Examining the value and quality of health economic analyses: implications of utilizing the QHES. J Manag Care Pharm JMCP. 2003;9:53–61.
Micieli A, Wijeysundera HC, Qiu F, Atzema CL, Singh SM. A decision analysis of percutaneous left atrial appendage occlusion relative to novel and traditional oral anticoagulation for stroke prevention in patients with new-onset atrial fibrillation. Med Decis Mak Int J Soc Med Decis Mak. 2016;36:366–74.
Reddy VY, Akehurst RL, Armstrong SO, Amorosi SL, Brereton N, Hertz DS, et al. Cost effectiveness of left atrial appendage closure with the Watchman device for atrial fibrillation patients with absolute contraindications to warfarin. Eur Eur Pacing Arrhythm Card Electrophysiol J Work Groups Card Pacing Arrhythm Card Cell Electrophysiol Eur Soc Cardiol. 2016;18:979–86.
Singh SM, Micieli A, Wijeysundera HC. Economic evaluation of percutaneous left atrial appendage occlusion, dabigatran, and warfarin for stroke prevention in patients with nonvalvular atrial fibrillation. Circulation. 2013;127:2414–23.
Lee VW-Y, Tsai RB-C, Chow IH-I, Yan BP-Y, Kaya MG, Park J-W, et al. Cost-effectiveness analysis of left atrial appendage occlusion compared with pharmacological strategies for stroke prevention in atrial fibrillation. BMC Cardiovasc Disord. 2016;16:167.
Reddy VY, Akehurst RL, Armstrong SO, Amorosi SL, Beard SM, Holmes DR. Time to cost-effectiveness following stroke reduction strategies in AF: warfarin versus NOACs versus LAA closure. J Am Coll Cardiol. 2015;66:2728–39.
Freeman JV, Hutton DW, Barnes GD, Zhu RP, Owens DK, Garber AM, et al. Cost-effectiveness of percutaneous closure of the left atrial appendage in atrial fibrillation based on results from PROTECT AF versus PREVAIL. Circ Arrhythm Electrophysiol. 2016;9:e003407.
Saw J, Bennell MC, Singh SM, Wijeysundera HC. Cost-effectiveness of left atrial appendage closure for stroke prevention in atrial fibrillation patients with contraindications to anticoagulation. Can J Cardiol. 2016;32:1355.e9–1355.e14.
Health Quality Ontario. Left atrial appendage closure device with delivery system: a health technology assessment. Ont Health Technol Assess Ser. 2017;17:1–106.
Maisel WH. Left atrial appendage occlusion–closure or just the beginning? N Engl J Med. 2009;360:2601–3.
Abrishami P, Boer A, Horstman K. Value in co-creation: subjecting innovative in-hospital technologies to multi-stakeholder appraisal. Int J Hosp Based Health Technol Assess. 2017;2017:12–30.
Author information
Authors and Affiliations
Contributions
EN and NM designed and performed the study. EN, NM and JP analysed the data. EN, NM, JP and PP contributed to the writing of the manuscript.
Corresponding author
Ethics declarations
Conflict of interest
Etienne Nédellec, Judith Pineau, Patrice Prognon and Nicolas Martelli have no conflicts of interest to declare and no specific funding has been provided for this research.
Funding
None.
Data availability statement
All data generated or analysed during this study are included in this published article and its supplementary information files (see also Online Supplementary Material, File 4).
Electronic supplementary material
Below is the link to the electronic supplementary material.
Rights and permissions
About this article
Cite this article
Nédellec, E., Pineau, J., Prognon, P. et al. Level of Evidence in Economic Evaluations of Left Atrial Appendage Closure Devices: A Systematic Review. Appl Health Econ Health Policy 16, 793–802 (2018). https://doi.org/10.1007/s40258-018-0429-z
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40258-018-0429-z